Cardiac allograft tolerance can be achieved in nonhuman primates by donor bone marrow and kidney cotransplantation
Science Translational Medicine · 2025
DOI: 10.1126/scitranslmed.ads0255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2025. Verfasst von Makoto Tonsho und 24 weiteren Autor:innen. Beteiligte Einrichtung: Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Heart Transplantation, Bone Marrow Transplantation, Transplantation Tolerance. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Long-term, immunosuppression-free allograft survival has been induced in human and nonhuman primate (NHP) kidney recipients after nonmyeloablative conditioning and donor bone marrow transplantation (DBMT), resulting in transient mixed hematopoietic chimerism. However, the same strategy has consistently failed in NHP heart transplant recipients. Here, we investigated whether long-term heart allograft survival could be achieved by cotransplanting kidneys from the same donor. Cynomolgus monkeys were transplanted with heart allografts alone or heart and kidney allografts from the same major histocompatibility complex (MHC)–mismatched donors. All animals except one received DBMT, either at the same time or after a 2- to 4-month delay, plus short-term costimulation blockade and calcineurin inhibitor treatment. Long-term, immunosuppression-free heart allograft survival was consistently achieved in heart/kidney, but not heart-alone, recipients. This was not associated with greater donor/recipient histocompatibility or altered lymphoid cell reconstitution after conditioning. The maintenance of tolerance after heart/kidney transplantation was associated with the presence of forkhead box P3 (Foxp3 + ) regulatory T cell (T reg )–rich organized lymphoid structures in kidneys but not hearts. Substituting high-dose erythropoietin treatment for kidney transplantation was unsuccessful, suggesting that it was not the sole mechanism of action. RNA sequencing analysis revealed that gene expression in hearts from tolerant recipients closely resembled that in hearts from chronically immunosuppressed recipients but differed markedly from rejecting allografts and naïve hearts. A version of this protocol may be able to induce tolerance in patients with end-stage heart and kidney failure who require combined heart and kidney transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA.
- Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.
- Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA.
- Division of Transplantation, Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA.
- Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
- Translational Transplant Research Center and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
ORCID-Profile: Makoto Tonsho, Jane M O, Kaitlan Ahrens, Kortney Robinson, Wiebke Sommer, Parth M Patel, Kyu Ha Huh, Cynthia L Miller, Abbas Dehnadi, Isabel Hanekamp, Ivy A Rosales, Robert B Colvin, Alessandro Alessandrini, Robert L Fairchild, Peter S Heeger, James S Allan, Tatsuo Kawai, Gilles Benichou, Joren C Madsen
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIH HHS
Zitieren
APA
Tonsho, M., O, J. M., Ahrens, K., Robinson, K., Sommer, W., Boskovic, S., Patel, P. M., Becerra, D. C., Huh, K. H., Miller, C. L., Dehnadi, A., Hanekamp, I., Rosales, I. A., Colvin, R. B., Sachs, D. H., Alessandrini, A., Cosimi, A., Fairchild, R. L., Cravedi, P., …, & Madsen, J. C. (2025). Cardiac allograft tolerance can be achieved in nonhuman primates by donor bone marrow and kidney cotransplantation. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.ads0255
Vancouver
Tonsho M, O JM, Ahrens K, Robinson K, Sommer W, Boskovic S, et al. Cardiac allograft tolerance can be achieved in nonhuman primates by donor bone marrow and kidney cotransplantation. Science Translational Medicine. 2025. doi:10.1126/scitranslmed.ads0255
BibTeX
@article{Tonsho2025,
author = {Tonsho, Makoto and O, Jane M and Ahrens, Kaitlan and Robinson, Kortney and Sommer, Wiebke and Boskovic, Svjetlan and Patel, Parth M and Becerra, David C and Huh, Kyu Ha and Miller, Cynthia L and Dehnadi, Abbas and Hanekamp, Isabel and Rosales, Ivy A and Colvin, Robert B and Sachs, David H and Alessandrini, Alessandro and Cosimi, A and Fairchild, Robert L and Cravedi, Paolo and Bin, Sofia and Heeger, Peter S and Allan, James S and Kawai, Tatsuo and Benichou, Gilles and Madsen, Joren C},
title = {Cardiac allograft tolerance can be achieved in nonhuman primates by donor bone marrow and kidney cotransplantation},
journal = {Science Translational Medicine},
year = {2025},
doi = {10.1126/scitranslmed.ads0255}
}
EUVIMED